Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models
Year: 2019
Type: article
Source: Cell Metabolism
Authors: Chung-Han Hsieh, Li Li, Roeland Vanhauwaert, Kong T. Nguyen, Mary D. Davis, Guojun Bu, Zbigniew K. Wszolek, Xinnan Wang
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Michael J. Fox Foundation for Parkinson's Research, Mayo Clinic, California Institute for Regenerative Medicine, Esther A. and Joseph Klingenstein Fund, Belgian American Educational Foundation, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Stanford University, Biogen, Servier, H. Lundbeck A/S, National Institutes of Health, Genentech, National Institute on Aging, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences
OpenAlex ID: W2975042496
